Dr. Eugene Sullivan is the chief product strategy officer at Insmed. Promoted to this position earlier this year, Eugene is also the first to hold the role. He joined Insmed in 2015 as chief medical and scientific officer. Most recently, Eugene helped complete the enrollment in a large, multi-national, Phase 3 clinical trial in a rare disease called refractory nontuberculous mycobacteria (NTM) lung disease caused by Mycobacterium avium complex (MAC), with Insmed’s lead product candidate, Amikacin Lipsomal Inhalation Suspension (ALIS), the results of which are expected later this year. If the trial is successful, “the trial will form the basis of a marketing application for our lead product,” he says.
A native of Washington, D.C., Eugene earned his medical degree at the University of Maryland and conducted his internship and residency in internal medicine at the Medical College of Virginia. He completed his fellowship in pulmonary and critical care medicine at the University of Colorado Health Sciences Center, and received a master’s in pulmonary vascular disease from the University of Bologna, Italy. Prior to joining Insmed, he was chief medical officer at United Therapeutics.
Eugene is a third-generation Irish American with paternal roots in Macroom and Ballyvourney, County Cork. He is married to fellow doctor Patricia M. Sullivan, with whom he has three children, Aidan, Darby, and Mae, and is currently based in Maryland.